DOPPLER-CIP

Determining Optimal non-invasive Parameters for the Prediction of Left vEntricular morphologic and functional Remodeling in Chronic Ischemic Patients

 Coordinatore KATHOLIEKE UNIVERSITEIT LEUVEN 

 Organization address address: Oude Markt 13
city: LEUVEN
postcode: 3000

contact info
Titolo: Ms.
Nome: Elke
Cognome: Lammertyn
Email: send email
Telefono: +32 16 32 06 21
Fax: +32 16 32 65 15

 Nazionalità Coordinatore Belgium [BE]
 Sito del progetto http://www.doppler-cip.eu
 Totale costo 3˙426˙433 €
 EC contributo 2˙614˙997 €
 Programma FP7-HEALTH
Specific Programme "Cooperation": Health
 Code Call FP7-HEALTH-2007-B
 Funding Scheme CP-FP
 Anno di inizio 2009
 Periodo (anno-mese-giorno) 2009-05-01   -   2015-02-28

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    KATHOLIEKE UNIVERSITEIT LEUVEN

 Organization address address: Oude Markt 13
city: LEUVEN
postcode: 3000

contact info
Titolo: Ms.
Nome: Elke
Cognome: Lammertyn
Email: send email
Telefono: +32 16 32 06 21
Fax: +32 16 32 65 15

BE (LEUVEN) coordinator 751˙891.60
2    LINKOPINGS UNIVERSITET

 Organization address address: CAMPUS VALLA
city: LINKOPING
postcode: 581 83

contact info
Titolo: Ms.
Nome: Elisabeth
Cognome: Helltegen
Email: send email
Telefono: +46 13 222101
Fax: +46 13 123285

SE (LINKOPING) participant 643˙214.40
3    OSLO UNIVERSITETSSYKEHUS HF

 Organization address address: FORSKNINGSVEIEN 2B
city: OSLO
postcode: 373

contact info
Titolo: Dr.
Nome: Geir
Cognome: Gogstad
Email: send email
Telefono: +47 23 07 57 01
Fax: +47 23 07 50 00

NO (OSLO) participant 287˙090.40
4    KING'S COLLEGE HOSPITAL NHS TRUST

 Organization address address: DENMARK HILL 1
city: LONDON
postcode: SE5 9RS

contact info
Titolo: Ms.
Nome: Kirsty
Cognome: Hedditch
Email: send email
Telefono: +44 20 3299 4949
Fax: +44 20 3299 5515

UK (LONDON) participant 215˙115.00
5    SERVICIO MADRILENO DE SALUD

 Organization address address: PLAZA CARLOS TRIAS BERTRAN 7
city: MADRID
postcode: 28020

contact info
Titolo: Mr.
Nome: Antonio
Cognome: Portolés Perez
Email: send email
Telefono: +34 91 330 37 93
Fax: +34 91 330 35 15

ES (MADRID) participant 183˙152.40
6    CONSIGLIO NAZIONALE DELLE RICERCHE

 Organization address address: Piazzale Aldo Moro 7
city: ROMA
postcode: 185

contact info
Titolo: Mr.
Nome: Eugenio
Cognome: Picano
Email: send email
Telefono: 390503000000
Fax: 390503000000

IT (ROMA) participant 159˙184.00
7    KING'S COLLEGE LONDON

 Organization address address: Strand
city: LONDON
postcode: WC2R 2LS

contact info
Titolo: Mr.
Nome: Paul
Cognome: Labbett
Email: send email
Telefono: +44 20 7848 8184
Fax: 442078000000

UK (LONDON) participant 112˙832.40
8    ADVANCED MEDICAL IMAGING DEVELOPMENT SRL

 Organization address address: VIA CIRCONVALLAZIONE OCCIDENTALE 2
city: SULMONA
postcode: 67039

contact info
Titolo: Dr.
Nome: Giovanni
Cognome: Tonti
Email: send email
Telefono: +39 348 222 3037
Fax: +39 0574 070853

IT (SULMONA) participant 100˙825.20
9    VARSINAIS-SUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA

 Organization address address: KIINAMYLLYNKATU 4-8
city: TURKU
postcode: 20520

contact info
Titolo: Ms.
Nome: Anne
Cognome: Lindqvist
Email: send email
Telefono: +358 2 313 1100
Fax: +358 2 313 1100

FI (TURKU) participant 99˙237.60
10    UNIVERSITA DI PISA

 Organization address address: Lungarno Pacinotti 43/44
city: PISA
postcode: 56126

contact info
Titolo: Ms.
Nome: Andrea
Cognome: Degl'innocenti
Email: send email
Telefono: +39 050 995320
Fax: +39 050 995334

IT (PISA) participant 62˙454.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

patients    artery    infarction    extract    clinical    made    cip    recovery    morphologic    ischemic    determining    chronic    ing    function    left    imaging    morbidity    heart    disease    functional    remodelling    myocardial    optimal    primary    myocardium    determine    direct    mortality    prognostic    coronary    ventricular    cardiovascular    prediction    examinations    decision    centre    advantages    modality    patient    cad    sub    invasive    doppler    arterial    adverse    predict    had    treatments    date   

 Obiettivo del progetto (Objective)

'Coronary artery disease (CAD) remains the primary cause of cardiovascular morbidity and mortality in Europe. In current clinical practice, patients with chronic CAD are followed using non-invasive imaging methodologies for possible adverse morphologic remodelling and functional recovery of the myocardium before the decision for invasive examinations and treatments is taken. Technological developments have brought about several newer imaging methodologies (and associated parameters) that have shown accurate prognostic results under study conditions in selected patient populations. Each of these methodologies offers intrinsic advantages and disadvantages due to the physiologic processes it tries to assess, due to the technology it requires or due to its availability (often determined by its associated cost). However, to date, no large scale studies have made a direct comparison of the different methodologies towards predicting adverse morphologic remodelling or functional recovery of the myocardium after medical therapy. The lack of such information results in a sub-optimal use of the methodologies at hand. The aim of DOPPLER-CIP is therefore to conduct a multi-centre clinical study including about 1200 patients in order to determine the optimal prognostic parameters derived from (new) non-invasive imaging for a patient presenting with suspected chronic ischemic heart disease. The modality used to extract these parameters is of secondary importance. However, as both the accuracy and the cost related to extracting a particular parameter is modality-dependent, DOPPLER-CIP will also make a cost-effectiveness analysis in order to determine which modality should preferentially be used to extract the clinically most relevant parameter.'

Introduzione (Teaser)

Comparison of the imaging modalities available for the prediction of remodelling in coronary artery disease (CAD) should help physicians make a more informed diagnostic decision.

Descrizione progetto (Article)

CAD remains the primary cause of cardiovascular morbidity and mortality in Europe. CAD is defined by arterial narrowing leading to an imbalance between myocardial oxygen consumption and supply (ischaemia) and ultimately coronary occlusion, resulting in myocardial infarction. This induces adverse changes in heart morphology and functional deterioration.

Treatment entails specific medication and often the restoration of blood flow through techniques like balloon angioplasty or a venous or arterial vessel graft to surgically bypass the stenosis. Given the associated risks of such invasive examinations and treatments, it is necessary to predict the morphologic remodelling and functional recovery of the myocardium.

A number of non-invasive imaging methodologies have been developed that could be used to predict remodelling. However, to date, no large scale studies have made a direct comparison of the different methodologies, resulting in their sub-optimal use.

The EU-funded http://www.dopplercip.be/ (DOPPLER-CIP) (Determining optimal non-invasive parameters for the prediction of left ventricular morphologic and functional remodelling in chronic ischemic patients) project conducted a multi-centre clinical study. Their objective was determining the most cost-effective imaging modality as well as the optimal prognostic parameters of each methodology.

The consortium recruited over 650 patients who undertook various examination tests during their first and follow-up visit two years later. Of these patients, over 50 % had no previous myocardial infarction, 36 % had previous infarction but preserved left ventricular function while 10 % had previous infarction and poor left ventricular function.

Analysis of the echocardiographic, the nuclear (SPECT) and the magnetic resonance imaging examinations should provide a direct comparison of the prognostic advantages of each modality.

The DOPPLER-CIP study outcomes should provide a better definition of potentially adverse conditions in CAD patients. Better prognosis of adverse morphological or functional remodelling events in cardiovascular patients should positively impact the quality of healthcare they receive.

Altri progetti dello stesso programma (FP7-HEALTH)

PATHONGEN-TRACE (2012)

Next Generation Genome Based High Resolution Tracing of Pathogens

Read More  

BIO-NMD (2009)

Identifying and validating pre-clinical biomarkers for diagnostics and therapeutics of Neuromuscular Disorders

Read More  

TUMIC (2008)

An integrated concept of tumor metastasis: implications for therapy

Read More